Is atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion clinically significant?

Area of Science:

• Gynecology
• Oncology
• Cervical Cancer Screening

Background:

• Atypical squamous cells, cannot exclude HSIL (ASC-H) is a cytologic finding requiring further investigation.
• The precise cumulative risk of high-grade cervical intraepithelial neoplasia (CIN) 2 or 3 in ASC-H patients is not well-established.

Purpose of the Study:

• To determine the cumulative incidence of CIN 2 or 3 in patients diagnosed with ASC-H.
• To evaluate the efficacy of colposcopy in detecting CIN 2 or 3 in this patient population.

Main Methods:

• Retrospective analysis of patients with ASC-H referred to a dysplasia clinic.
• Initial evaluation included colposcopy, endocervical curettage, and biopsies.
• Follow-up evaluations at 6 and 12 months with CIN 2 or 3 as the endpoint.

Main Results:

• 229 patients with ASC-H (mean age 32.8 years) were analyzed.
• Initial colposcopy revealed CIN 2 or 3 in 10.0% of patients.
• The cumulative risk of CIN 2 or 3 at 12 months was 12.2%.

Conclusions:

• Colposcopic evaluation of ASC-H cytology detects CIN 2 or 3.
• The detection rate may be lower than previously reported, suggesting a need for refined management guidelines.